Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/163049
Title: | Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain |
Author: | Darbà, Josep Ascanio, Meritxell |
Keywords: | Endocrinologia Neurologia Tumors Endocrinology Neurology Tumors |
Issue Date: | 2019 |
Publisher: | Maghira & Maas |
Abstract: | In Spain it is necessary to conduct additional studies to determine place in therapy and cost-effectiveness of a drug. The main objective of this study is to identify all drug assessments and health technology assessment reports of the drugs for gastroenteropancreatic (GEP) neuroendocrine tumors (NET) at a national, regional and hospital level and to summarize the efficacy in terms of outcome measures, adverse events, economic impact and final recommendations. |
Note: | Reproducció del document publicat a: http://www.nel.edu/therapy-for-gastroenteropancreatic-neuroendocrine-tumors-drug-evaluation-reports-review-in-spain-2653/ |
It is part of: | Neuroendocrinology Letters, 2019, vol. 39, num. 8, p. 537-543 |
URI: | http://hdl.handle.net/2445/163049 |
ISSN: | 0172-780X |
Appears in Collections: | Articles publicats en revistes (Economia) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
691114.pdf | 798.35 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License